Position in ANAB
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$43,056,427
+$14,203,888 QoQ
Shares Held
637,873
-18.3% QoQ
Ownership
2.19%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 211 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,515,789 across 520 Biotechnology names. ANAB ranks #90 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in ANAB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,056,427 | 637,873 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $28,852,539 | 520,241 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $22,761,068 | 469,494 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $14,502,404 | 473,626 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $10,286,546 | 463,358 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $9,130,769 | 491,167 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $6,442,568 | 486,597 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $15,590,909 | 465,401 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $11,328,770 | 452,065 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $9,496,730 | 421,703 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $8,998,649 | 420,105 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $7,176,688 | 399,594 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $8,055,046 | 396,020 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $8,669,334 | 398,406 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $12,140,766 | 391,764 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $9,402,978 | 368,599 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,535,828 | 371,224 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $8,803,414 | 355,838 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $13,130,653 | 377,860 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $9,734,235 | 358,932 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $9,960,821 | 384,142 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $8,499,662 | 394,415 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $7,671,483 | 356,814 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,542,396 | 375,757 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $7,811,163 | 349,650 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $5,052,704 | 357,587 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||